B2M and ovarian cancer: B2M is a small, non-glycosylated polypeptide (Hofbauer et al., 2021) elevated in ovarian cancer and critical to mediating tumorigenesis, metastasis, and angiogenesis through various signaling pathways (Sun et al., 2016).